Technology solutions
Carl Zeiss Meditec has completed the acquisition of ianTECH
Colin Kerr
Published: Friday, February 1, 2019
Carl Zeiss Meditec has completed the acquisition of ianTECH, a privately held company focused on technology solutions for micro-interventional cataract surgery headquartered in
Reno, Nevada.
“Cataract surgery has been dependent on phaco technology for over 50 years. ZEISS believes that the market needs a fresh, innovative approach in the field of phaco. ianTECH’s surgical technology is designed to change the future of managing cataracts,” said a spokeswoman.
www.zeiss.com/med
Tags: cataract, refractive
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
How Many Surgeries Equal Surgical Proficiency?
Internet, labs, simulators, and assisting surgery all contribute.
Improving Clinical Management for nAMD and DME
Global survey data identify barriers and opportunities.
Are Postoperative Topical Antibiotic Drops Still Needed?
Cataract surgeons debate the benefits of intracameral cefuroxime prophylaxis.
Emerging Technology for Detecting Subclinical Keratoconus
Brillouin microscopy shows promise in clinical studies.
Knowing Iris Repair: Modified Trifold Technique
Part eight of our series covers the modified trifold technique for large iris defects.
It’s All About Biomechanics!
Increasing the pool of patients eligible for refractive surgery.
Uncovering More Safe and Quick Options
Different strategies, such as PresbyLASIK, can offer presbyopes good outcomes.
Topography-Guided PRK for Keratoconus
Improving visual acuity in patients with keratoconus.
Defining AMD Treatment Protocol
Treatments trending to fewer injections for better results.